Medical
Peritoneal Mesothelioma Treatment in 2026: 5-Year Survival Rates Reach 59% With CRS-HIPEC
David Foster
March 5, 2026
Peritoneal mesothelioma treatment 2026: CRS-HIPEC surgery pushes 5-year survival to 59%, median 4-8 years. Plus emerging immunotherapy and PIPAC options.
13 min read 6 FAQs
Read